| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/31/2006 | WO2005120577A3 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity |
| 08/31/2006 | WO2005067890A3 Controlled release cgrp delivery composition for cardiovascular and renal indications |
| 08/31/2006 | WO2005065717A3 Liquid formulations of antibody conjugates |
| 08/31/2006 | WO2005010163A3 Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv) |
| 08/31/2006 | US20060194954 Immunoadhesin protein for use as tools in targeting preferential cells for destruction |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194940 Water-soluble polymer alkanals |
| 08/31/2006 | US20060194775 Estradiol metabolites for the treatment of pulmonary hypertension |
| 08/31/2006 | US20060194743 Method for inhibiting acrylamide formation and use thereof |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194729 Method of promoting natural bypass |
| 08/31/2006 | US20060194722 orally administering to human a composition comprising salmon calcitonin in free or salt form and a delivery agent selected from N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC), N-(10-[2-hydroxybenzoyl]amino)decanoic acid (SNAD), N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAG), and disodium salts |
| 08/31/2006 | US20060194721 Tissue regeneration |
| 08/31/2006 | US20060194717 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 08/31/2006 | US20060194716 Polyacid glycopeptide derivatives |
| 08/31/2006 | US20060194715 Proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/31/2006 | US20060194204 Gene expressed in prostate cancer, methods and use thereof |
| 08/31/2006 | US20060194197 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 08/31/2006 | US20060193906 Sugar-modified liposome and products comprising the liposome |
| 08/31/2006 | US20060193905 Direct cellular energy delivery system |
| 08/31/2006 | US20060193904 Encapsulation of drugs in liposomes; encapsulated transition metal ions and encapsulated drugs, where if the drug is soley doxorubicin, the metal ion is not solely manganese, and the liposomes do not comprise an ionophore |
| 08/31/2006 | US20060193902 Pharmaceutical compositions containing active agents having a lactone group and transition metal ions |
| 08/31/2006 | US20060193901 Particularly drugs and cosmetic agents; an ethoxylated oil, fatty acid, fatty alcohol, or fatty amine having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 08/31/2006 | US20060193896 Process for manufacturing a delivery system for active components as part of an edible composition |
| 08/31/2006 | US20060193895 Additive for food and beverage, pharmaceutical composition, GLUT4 translocator, and method for translocating GLUT4 |
| 08/31/2006 | US20060193868 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils |
| 08/31/2006 | US20060193867 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 08/31/2006 | US20060193854 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 08/31/2006 | US20060193834 Antiprotozal composition |
| 08/31/2006 | US20060193823 Hydrolytically degradable carbamate derivatives of poly (Ethylene Glycol) |
| 08/31/2006 | US20060193798 Aqueous Polymer Dispersion |
| 08/31/2006 | US20060193783 Low dose corticosteroid composition |
| 08/31/2006 | US20060193778 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 08/31/2006 | US20060193773 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma |
| 08/31/2006 | US20060193771 Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins |
| 08/31/2006 | US20060191850 Method and a device for preparing a medical liquid |
| 08/31/2006 | US20060191375 Methods for fine powder formation |
| 08/31/2006 | DE19952957B4 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 08/31/2006 | CA2805761A1 Nanoparticles of gemcitabine derivatives |
| 08/31/2006 | CA2601938A1 Transport of nano- and macromolecular structures into cytoplasm and nucleus of cells |
| 08/31/2006 | CA2599121A1 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies |
| 08/31/2006 | CA2598666A1 Intranasal administration of active agents to the central nervous system |
| 08/31/2006 | CA2598031A1 Aqueous topical gel of high stability based on metronidazole and method of preparation |
| 08/31/2006 | CA2594127A1 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1695991A1 Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 08/30/2006 | EP1695978A1 Nucleic acid ligands |
| 08/30/2006 | EP1695718A2 Biodegradable polyester and Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 08/30/2006 | EP1695717A1 Transport of nano-and macromolecular structures into cytoplasm and nucleus of cells |
| 08/30/2006 | EP1695708A2 Pharmaceutical composition |
| 08/30/2006 | EP1695707A1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis |
| 08/30/2006 | EP1695701A2 HFA suspension formulations comprising an anticholinergic agent |
| 08/30/2006 | EP1695699A1 Drug-containing grains and solid preparation containing the grains |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1695696A1 Liposome |
| 08/30/2006 | EP1695094A2 Disintegratable films for diagnostic devices |
| 08/30/2006 | EP1694845A1 Anticarcinoma antibidies and uses thereof |
| 08/30/2006 | EP1694826A1 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers |
| 08/30/2006 | EP1694709A1 Recombinant anti-cd64-immunotoxins |
| 08/30/2006 | EP1694696A1 Delivery peptides ,their constructs with active agents and use |
| 08/30/2006 | EP1694400A1 Method and system for rapid transdermal administration |
| 08/30/2006 | EP1694375A2 Electrically conductive adhesive hydrogels with solubilizer |
| 08/30/2006 | EP1694363A2 Pegylated small molecules |
| 08/30/2006 | EP1694362A1 Improved parasiticide composition |
| 08/30/2006 | EP1694347A2 Glycopegylated erythropoietin |
| 08/30/2006 | EP1694319A1 Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia |
| 08/30/2006 | EP1694315A2 Glycopegylated factor ix |
| 08/30/2006 | EP1694311A2 Chewable soft capsules containing ungelatinized starch |
| 08/30/2006 | EP1694307A2 Methods for the treatment of cancer |
| 08/30/2006 | EP1694306A2 Powder containing low-molecular dextran and method for producing the same |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1694296A1 Injectable composition |
| 08/30/2006 | EP1694295A1 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability |
| 08/30/2006 | EP1694294A1 Pharmaceutical compositions with synchronized solubilizer release |
| 08/30/2006 | EP1694292A2 Therapeutic foam comprising a sclerosing solution |
| 08/30/2006 | EP1694274A2 Glycopegylated granulocyte colony stimulating factor |
| 08/30/2006 | EP1694242A1 Pharmaceutical formulations of camptothecins and process for making same |
| 08/30/2006 | EP1608407B1 Dispersible formulation of an anti-inflammatory agent |
| 08/30/2006 | EP1606298B1 Direct compressible trehalose solids |
| 08/30/2006 | EP1448608B1 Carrageenan-containing composition with improved gelling properties |
| 08/30/2006 | EP1399128B1 Composition for the treatment of diseases which affect animals' hooves |
| 08/30/2006 | EP1385519B1 Compounds for treating inflammatory diseases |
| 08/30/2006 | EP1276459B1 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 08/30/2006 | EP1272183B1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 08/30/2006 | EP1250056B1 Composition for intestinal delivery |
| 08/30/2006 | EP1084214B1 Contaminant reduced marine oil |
| 08/30/2006 | EP0755270B1 Microcapsules, method of making and their use |
| 08/30/2006 | CN1826381A Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 08/30/2006 | CN1826359A Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same |
| 08/30/2006 | CN1826138A Rg1 antibodies and uses thereof |
| 08/30/2006 | CN1826132A Formulation for a protein pharmaceutical without added human serum albumin (HSA) |
| 08/30/2006 | CN1826123A Acute inflammatory condition treatment |
| 08/30/2006 | CN1826097A Transnasal microemulsions containing diazepam |
| 08/30/2006 | CN1824324A Medicine for repairing and treating viscera injury |
| 08/30/2006 | CN1824323A Doramectin injection fluid containing soyban oil |
| 08/30/2006 | CN1824322A Solubilization method of acyclovir in acyclovir injection liquid |
| 08/30/2006 | CN1824321A Yanhuning freeze dried powder for injection and its preparation method |
| 08/30/2006 | CN1824314A Slow release agent containing hormone kind anti cancer medicine |